Dr Sehdev worked for 25 years as a general medical oncologist in a large urban community centre before returning to Ottawa where he now leads the breast cancer medical oncology group. He has been involved in advocacy and educational program development
Join us for 60 minute webinar from the safety of your home or office.
At the end of this unaccredited session participants will:
Identify early breast cancers that benefit from genomic profiling to guide adjuvant
Understand recent trial evidence supporting de-escalation of adjuvant treatment.
Identify limitations of current genomic profiling tools.
This session will be a review of landmark prospective early stage breast cancer randomized trials guiding the selection and application of genomic profiling of early stage breast cancers.